speak with their health care provider.
The long delay between the ap proval of Budeprion XL 300 mg in late 2006 and the appearance of the bioequivalence results report ed here, during which the prod uct remained listed by the FDA as a generic substitute for Well butrin XL 300 mg, is problemat ic. Because of the risk of seizure associated with high doses of bu propion, the agency initially took a conservative approach to trial design. Today, the FDA has greater understanding of the risk of seizure with bupropion. At the time of the sponsor's 2007 study, some critics considered its design to be flawed. The results of the recent study by the FDA show that a design entailing the enrollment of a more accessible trial population might well have brought the bioequiv alence data to light sooner. In retrospect, the conservative approach did not provide the right conclusions re garding thera peutic equivalence in a timely manner.
We do not believe that the re sults of the FDA study should cause concern regarding the over all reliability of the agency's ap proval process for generic drugs, including the use of extrapola tion, when scientifically appro priate. Technical aspects of the Budeprion formulation may have led to the failure of extrapolation in this case. More information on this issue will be generated by the other sponsors' bioequivalence studies. The other 300mg gener ic bupropion products do not use the same technology as Bude prion. The use of extrapolation for the approval of multiple strengths of generic drugs, which incorporates sciencebased reason ing, has been generally success ful, and the FDA will continue to refine its approach to this method. The agency will also move more aggressively to per form its own studies when data are urgently needed. We wish to assure the public that drug prod ucts that are approved for gener ic use will continue to be held to high standards of quality, safety, and efficacy. Although the report didn't as sess the reasons for higher billing levels, its findings have been am plified by investigative reports in the media suggesting that fraud is the cause. On September 24, 2012, a formal letter from the U.S. Departments of Justice and Health and Human Services to hospital leaders warned of an es calated effort to prevent fraud and abuse and explicitly linked higher bills to "gaming" made possible by new electronic health record (EHR) technology. The OIG report addressed only physician billing, not hospital billing, and the office has initiated further study into usage of all CPT codes. Although it's possible that "upcoding" facilitated by increas ing use of EHRs has contributed to the trend, other causes such as changing demographics, shift ing practice patterns, and the ED's evolving role in the health care system must also be considered.
To explore these potential con tributors, I analyzed a nationally representative sample of Medicare ED discharges in the National Hospital Ambulatory Medical Care Surveys, using methods described previously and detailed in the Sup plementary Appendix (available with the full text of this article at NEJM.org). Medicare ED visits that lead to hospitalization or transfer. Between 2001 and 2009, the average age among all patients discharged from the ED increased by 0.18 years annually, but among Medicare patients discharged from the ED, the mean age trended downward (see graph). In 2006, 38% of these Medicare patients were younger than 65 years, whereas only 19% of the total Medicare population was in that age group. The disposition of Medicare patients under 65 after an ED visit is often more diffi cult than that of older Medicare patients, because on average, such patients have worse selfreported health status and are more likely to be disabled, poor, or cognitive ly impaired. 3 In 2006, 33% of Medicare patients under 65 who were discharged from the ED were in the costly "dual eligible" cate gory also covered by Medicaid, whereas only 21% of all Medicare beneficiaries were dual eligibles.
Along with demographic chang es in the Medicare ED population, the overall health care system and the ED's role in medical care changed sharply during the de cade of the OIG study. The marked increase in use of new diagnostic technology in U.S. medicine was magnified in the ED, with its ready access to hospitalbased ad vanced imaging: computed tomog raphy (CT), magnetic resonance imaging, and ultrasonography (see graph). In the past decade, an in creasingly strained primary care infrastructure for adults has re sulted in greater use of the ED for firstcontact care. 4 Lack of stable "medical homes" encourages ED physicians to seek greater diag nostic certainty before discharg ing a patient. The three most common symptoms reported by Medicare patients who are ulti mately discharged from the ED are abdominal pain, chest pain, and shortness of breath -all challenging diagnostic problems that often necessitate testing that's unavailable in office set tings, in order to diagnose seri ous conditions. For example, technological innovations have revolutionized care for abdomi nal pain. Whereas surgical con sultation and hospitalization were once standard, multidetec tor CT now permits rapid risk stratification in the ED, often averting the need for admission or consultation for patients with negative tests. The diagnostic precision afforded by these tech nologies is increasingly expected by patients, physicians, and the public. Failure to diagnose pa tients' conditions carries heavy penalties for ED physicians and hospitals, whereas "overuse" of technology is ill defined, and penalties for it are less direct. The ED has also been affected by another major trend: hospitals' reduced inpatient capacity has led to widespread boarding of inpa tients in ED hallways. This trend contributes to shifting of work formerly done in inpatient wards to the ED, encouraging EDs to discharge patients with border line health status (who might have been admitted in the past) in order to reduce crowding and prolonged waits.
The result of these changes is an increasingly interventionist ED practice style, illustrated not only by increased imaging, but also by increased laboratory testing and initiation of IV fluids (see graph). Whether this trend has truly im proved patient safety and quality of care is unknown, but it has certainly increased the complexi ty of the medical decisionmaking component of documentation, which translates into higher phy sician billing.
Finally, the culture of billing for medical services changed with the implementation of evaluation andmanagement guidelines in the late 1990s. Physicians have adapted: some have become stu dents of the coding procedures, but many have outsourced billing to professional coders trained to search for keywords. Although many ED physicians don't know exactly what is billed in their name, physicians commonly re ceive regular feedback on their average billing performance through automated reports. Early adoption of electronic records by the ED may in part explain the sharper billing in creases in emergency medicine than in other clinical specialties. The EHR facilitates billing by presenting clickable checkboxes that easily satisfy codingcom plexity criteria, and some EHRs even issue notifications when documentation needed for cer tain billing levels has not been achieved. These changes ensure that no billable action goes un noticed and have reduced under coding. In fact, EHR vendors tout this effect to justify the cost of their products. In other ways, however, the EHR has become a doubleedged sword, potentially undermining its intended goal of reducing medical errors. Through put suffers when time that could be better spent with patients is wasted on elaborate documenta tion. The EHR may also facilitate improper behavior, such as click ing multiple items in the "review of systems" that patients were not directly asked about. Of even greater concern is the possibility of deliberate, systematic use of easily selected templates designed to ensure billing at the highest possible level, rather than pro moting validated clinical deci sion rules and protocols designed to improve efficiency and quality. Although ED physicians are in creasingly employed by hospitals, hospital chains, or contract groups with productivitybased compen sation, 5 the OIG holds individual physicians accountable for billing done in their name, regardless of who directly manages the billing operations.
What should be done about the trend in billing? A first step is to do what the OIG report pro poses: educate physicians about the importance of proper billing, review billing records to ensure that results match performance, and scrutinize physicians who consistently bill at higher levels than their peers. 1 From a broader perspective, the science of ED operations should be advanced to facilitate timely care. These ad vances should include the devel opment of a more effective busi ness model for the digital era that allows ED practitioners to get away from the computer and back to the bedside of sick and injured patients.
The EHR is one reason behind increased ED billing, and fraud may be facilitated by these new systems. However, this simple ex planation does not capture the broader story of what happened in U.S. EDs during the decade the OIG examined. While the ED has remained the social safety net, it has also gradually inherited roles previously handled by office based physicians. EDs have be come a central staging area for acutely ill patients, for the use of diagnostic technology, and for de cisions about hospital admission, all of which makes ED care in creasingly complex.
Disclosure forms provided by the author are available with the full text of this article at NEJM.org.
From the Department of Emergency Medicine, Emory University School of Medicine, Atlanta.
